As early as age 9, Allison felt like a "big toxic load"... She didn't know exactly what was wrong. But she was in a lot of pain. And she didn't have any friends.

Here's How Biotech Changes Lives By Marc Chaikin, founder, Chaikin Analytics As early as age 9, Allison felt like a "big toxic load"... She didn't know exactly what was wrong. But she was in a lot of pain. And she didn't have any friends. Still, Allison tried to live a productive life. She worked as an actor, a writer, and a radio DJ. But then, a late-night manic episode interrupted one of Allison's radio gigs. And after a trip to the hospital, doctors diagnosed her with bipolar disorder. Allison managed her condition for a decade or so before things got worse. After another hospital visit, she received antipsychotic medication for the first time. Once again, her condition was manageable. But years later, Allison's legs started to involuntarily kick. And her torso would randomly twist. Allison went to see a local doctor, who was less than sympathetic. As she later recalled, he said...   Young lady, you're going to need to suck it up. This isn't going to get any better for you. Allison tried to just "suck it up." But before long, she developed even more problems... Recommended Links: MUST-SEE BY MIDNIGHT TONIGHT: "This Is How I'd Invest $1 Million Today" Legendary investor Whitney Tilson just posted a new portfolio of stock picks. He isn't buying the Magnificent 7... Or putting an equal amount of cash into each. Instead, he's using the Monte Carlo Method to see which of 4,817 stocks could double your money. Click here to learn more, before it goes offline. 'I Found the Answer to Retirement' A man from New York came forward with his unique story of how he retired early and worry-free WITHOUT stocks... thanks to ONE single idea that anyone can use. Now he sees 16%-plus annual returns with legal protections... and he NEVER has to worry about another market crash again. Get the full story right here. Her mouth would clench and move on its own. Her eyes started to blink rapidly. And her shoulders, chest, and neck started to move by themselves. Folks in Allison's inner circle always understood what was happening. But when any of these involuntary movements occurred in public, strangers would glare and gawk at her. In short, Allison was suffering from a disorder called tardive dyskinesia ("TD"). TD is associated with drugs used to treat various forms of psychosis. These drugs aim to block dopamine – a chemical messenger that works between the brain and the rest of the body. But like any medication, side effects can happen. So in other words... Allison's bipolar-disorder medication was causing her TD. Allison could've gotten relief from the TD symptoms if she just stopped using the medication. But that would've brought back the psychotic behaviors. So Allison knew that wasn't the answer. Fortunately for Allison, everything changed for the better in May 2017. That's when a new, highly effective treatment for TD became available... Allison's quest to learn more about TD led her to discover this treatment. And after using it for just a couple of weeks, her body's uncontrollable movements subsided. Allison still suffers from TD today. But it doesn't dominate her life like before. Folks, this is the power of biotechnology. And it follows the latest recommendation I made in the space to paid subscribers of our Power Gauge Investor newsletter. Now, I can't give you all the details of that recommendation. It wouldn't be fair to paying subscribers. But still, you need to be aware of a major change taking place in this space... The SPDR S&P Biotech Fund's (XBI) rating in the Power Gauge flipped to "bullish" at the end of December. And XBI triggered a relative strength "buy" signal in our system last week. This means that the biotech space, as measured by XBI, has been outperforming the broad market recently. Over the past three months, XBI has soared about 29%. Meanwhile, the S&P 500 Index has climbed roughly 15% over that same time frame. Combined with the recent "buy" signal based on our proprietary measure of relative strength, this all points to more upside ahead. So, if you're not paying attention to biotech stocks today... I recommend you look into them. Good investing, Marc Chaikin P.S. As I mentioned, our latest recommendation in Power Gauge Investor is in the biotech space. It's the company behind Allison's life-changing treatment... This company isn't like most biotech firms. It's already profitable and financially strong. Furthermore, Wall Street doesn't fully realize how much potential growth lies ahead. And beyond that, many investors don't appreciate the value of the rest of the company's pipeline. Even better, the Power Gauge is "very bullish" on this stock today. If you aren't already a Power Gauge Investor subscriber, find out how to gain immediate access to this recommendation by clicking here. Market View Major Indexes and Notable Sectors     # Hld:     Bullish     Neutral     Bearish Dow 30 +0.33% 14 15 1 S&P 500 +1.02% 171 248 78 Nasdaq +1.69% 46 46 8 Small Caps -0.54% 592 965 364 Bonds -2.21% Communication Services +4.02% 9 9 1 — According to the Chaikin Power Bar, Large Cap stocks and Small Cap stocks are Bullish. Major indexes are mixed. *  *  *  * Sector Tracker Sector movement over the last 5 days Discretionary +3.29% Communication +2.65% Staples +2.12% Health Care +1.95% Industrials +1.9% Financial +0.85% Materials +0.7% Utilities +0.46% Information Technology +0.24% Real Estate -0.47% Energy -0.89% *  *  *  * Industry Focus Capital Markets Services 37 24 1 Over the past 6 months, the Capital Markets subsector (KCE) has outperformed the S&P 500 by +2.36%. Its Power Bar ratio, which measures future potential, is Very Strong, with more Bullish than Bearish stocks. It is currently ranked #6 of 21 subsectors and has moved down 2 slots over the past week. Top Stocks LPLA LPL Financial Holdin BK The Bank of New York PIPR Piper Sandler Compan *  *  *  * Top Movers Gainers META +20.32% EW +9.38% AMZN +7.87% CLX +5.62% GWW +5.41% Losers CHTR -16.51% GEN -11.25% FSLR -4.1% TECH -3.74% CMCSA -3.51% *  *  *  * Earnings Report Reporting Today Rating Before Open After Close TSN L, NXPI, SWKS, VRTX CAT, IDXX, ON, TDG SPG APD, HAS EL, FMC No earnings reporting today. Earnings Surprises CHTR Charter Communications, Inc. Q4 $7.07 Missed by $-1.77 SCCO Southern Copper Corporation Q4 $0.58 Missed by $-0.14 XOM Exxon Mobil Corporation Q4 $2.48 Beat by $0.27 REGN Regeneron Pharmaceuticals, Inc. Q4 $11.86 Beat by $1.11 BMY Bristol-Myers Squibb Company Q4 $1.70 Beat by $0.12 *  *  *  * You have received this e-mail as part of your subscription to PowerFeed. If you no longer want to receive e-mails from PowerFeed, click here. You're receiving this e-mail at edwardlorilla1986.paxforex@blogger.com. For questions about your account or to speak with customer service, call +1 (877) 697-6783 (U.S.), 9 a.m. - 5 p.m. Eastern time or e-mail info@chaikinanalytics.com. Please note: The law prohibits us from giving personalized investment advice. © 2024 Chaikin Analytics, LLC. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Chaikin Analytics, LLC. 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. www.chaikinanalytics.com. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Chaikin Analytics, LLC, does not recommend or endorse any brokers, dealers, or investment advisors. Chaikin Analytics forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Chaikin Analytics, LLC (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.